Advertisement
Screener

United Therapeutics Corporation (UTHR) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

United Therapeutics Corporation Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

United Therapeutics Corporation (UTHR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 300.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05

  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 300.00K shares, a 25.00% decline year-over-year.
  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 100.00K shares, a 0.00% change year-over-year.
  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 400.00K shares.
  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 400.00K shares, a 60.00% decline year-over-year.
  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 200.00K shares, a 50.00% decline from fiscal 2024.
  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 400.00K shares, a 33.33% increase from fiscal 2023.
  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 300.00K shares.
  • United Therapeutics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-30300.00K shares
10-Q · filed 2026-08-05
200.00K shares
10-Q · filed 2026-08-05
2026-03-31100.00K shares
10-Q · filed 2026-05-06
2025-12-31200.00K shares
10-K · filed 2026-02-25
2025-09-30400.00K shares
10-Q · filed 2025-10-29
300.00K shares
10-Q · filed 2025-10-29
2025-06-30400.00K shares
10-Q · filed 2026-08-05
300.00K shares
10-Q · filed 2026-08-05
2025-03-31100.00K shares
10-Q · filed 2026-05-06
2024-12-31400.00K shares
10-K · filed 2026-02-25
2024-09-300.00 shares
10-Q · filed 2025-10-29
500.00K shares
10-Q · filed 2025-10-29
2024-06-301.00M shares
10-Q · filed 2025-07-30
800.00K shares
10-Q · filed 2025-07-30
2024-03-31700.00K shares
10-Q · filed 2025-04-30
2023-12-31300.00K shares
10-K · filed 2026-02-25
2023-09-30500.00K shares
10-Q · filed 2024-10-30
200.00K shares
10-Q · filed 2024-10-30
2023-06-30200.00K shares
10-Q · filed 2024-07-31
100.00K shares
10-Q · filed 2024-07-31
2023-03-31100.00K shares
10-Q · filed 2024-05-01
2022-12-310.00 shares
10-K · filed 2025-02-26
2022-09-300.00 shares
10-Q · filed 2023-11-01
0.00 shares
10-Q · filed 2023-11-01
2022-06-300.00 shares
10-Q · filed 2023-08-02
0.00 shares
10-Q · filed 2023-08-02
2022-03-310.00 shares
10-Q · filed 2023-05-03
2021-12-31100.00K shares
10-K · filed 2024-02-21
2021-09-300.00 shares
10-Q · filed 2022-11-02
100.00K shares
10-Q · filed 2022-11-02
2021-06-300.00 shares
10-Q · filed 2022-08-03
100.00K shares
10-Q · filed 2022-08-03
2021-03-31200.00K shares
10-Q · filed 2022-05-04
2020-12-316.60M shares
10-K · filed 2023-02-22
2020-09-307.50M shares
10-Q · filed 2021-11-03
7.40M shares
10-Q · filed 2021-11-03
2020-06-307.20M shares
10-Q · filed 2021-08-04
7.40M shares
10-Q · filed 2021-08-04
2020-03-317.60M shares
10-Q · filed 2021-05-05
2019-12-317.20M shares
10-K · filed 2022-02-24
2019-09-308.00M shares
10-Q · filed 2020-10-28
7.10M shares
10-Q · filed 2020-10-28
2019-06-307.90M shares
10-Q · filed 2020-07-29
6.60M shares
10-Q · filed 2020-07-29
2019-03-315.30M shares
10-Q · filed 2020-04-29
2018-12-314.70M shares
10-K · filed 2021-02-24
2018-09-304.50M shares
10-Q · filed 2019-10-30
4.60M shares
10-Q · filed 2019-10-30
2018-06-305.50M shares
10-Q · filed 2019-07-31
4.70M shares
10-Q · filed 2019-07-31
2018-03-313.90M shares
10-Q · filed 2019-05-01
2017-12-313.30M shares
10-K · filed 2020-02-26
2017-09-303.70M shares
10-Q · filed 2018-10-31
3.10M shares
10-Q · filed 2018-10-31
2017-06-304.50M shares
10-Q · filed 2018-08-01
2.80M shares
10-Q · filed 2018-08-01
2017-03-311.80M shares
10-Q · filed 2018-05-02
2016-12-315.20M shares
10-K · filed 2019-02-27
2016-09-305.30M shares
10-Q · filed 2017-10-25
5.30M shares
10-Q · filed 2017-10-25
2016-06-306.50M shares
10-Q · filed 2017-07-27
5.30M shares
10-Q · filed 2017-07-27
2016-03-314.10M shares
10-Q · filed 2017-04-26
2015-12-313.80M shares
10-K · filed 2018-02-21
2015-09-303.00M shares
10-Q · filed 2016-10-27
3.03M shares
10-Q · filed 2015-10-27
4.10M shares
10-Q · filed 2016-10-27
4.11M shares
10-Q · filed 2015-10-27
2015-06-303.70M shares
10-Q · filed 2016-07-28
3.70M shares
10-Q · filed 2015-07-28
4.70M shares
10-Q · filed 2016-07-28
4.66M shares
10-Q · filed 2015-07-28
2015-03-315.60M shares
10-Q · filed 2016-04-28
5.61M shares
10-Q · filed 2015-04-28
2014-12-319.30M shares
10-K · filed 2017-02-22
9.27M shares
10-K · filed 2015-02-24
2014-09-3015.59M shares
10-Q · filed 2015-10-27
9.77M shares
10-Q · filed 2015-10-27
2014-06-309.93M shares
10-Q · filed 2015-07-28
9.81M shares
10-Q · filed 2015-07-28
2014-03-319.71M shares
10-Q · filed 2015-04-28
2013-12-3111.21M shares
10-K · filed 2016-02-25
2013-09-3010.09M shares
10-Q · filed 2014-10-28
10.48M shares
10-Q · filed 2014-10-28
2013-06-3010.48M shares
10-Q · filed 2014-07-29
11.03M shares
10-Q · filed 2014-07-29
2013-03-3111.03M shares
10-Q · filed 2014-04-29
2012-12-3111.86M shares
10-K · filed 2015-02-24
2012-09-3011.03M shares
10-Q · filed 2013-10-29
11.76M shares
10-Q · filed 2013-10-29
2012-06-3011.76M shares
10-Q · filed 2013-07-25
11.76M shares
10-Q · filed 2013-07-25
2012-03-3111.71M shares
10-Q · filed 2013-04-25
2011-12-3116.30M shares
10-K · filed 2014-02-25
2011-09-307.99M shares
10-Q · filed 2012-11-01
7.92M shares
10-Q · filed 2011-10-27
6.45M shares
10-Q · filed 2012-11-01
2011-06-305.55M shares
10-Q · filed 2012-07-26
5.39M shares
10-Q · filed 2012-07-26
2011-03-315.25M shares
10-Q · filed 2012-04-26
2010-12-3113.53M shares
10-K · filed 2013-02-26
2010-09-307.33M shares
10-Q · filed 2011-10-27
6.53M shares
10-Q · filed 2011-10-27
2010-06-306.50M shares
10-Q · filed 2011-07-28
6.31M shares
10-Q · filed 2011-07-28
2009-12-3113.43M shares
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Viatris Inc (VTRS)United States$20.008B-0.00
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17